About Helionics


Mike Connolly Mike Connolly – Chief Executive Officer
Mr. Connolly’s 25 years of leadership in the medical device industry includes broad experience in both operating and venture investing roles. He has co-founded several companies, two of which, Novacept and Cohesion Technologies, reached exits worth a combined $365M. Mr. Connolly has also led the regional office for the $400M venture capital firm vSpring (now Signal Peak). Most recently, Mr. Connolly served as CEO of the venture-backed device company Mirabilis Medica, leading its innovation from initial concept through advanced clinical trials. Earlier in his career, Mr. Connolly served as a Navy officer aboard a destroyer and taught physics at the U.S. Naval Academy. He has an MBA from Stanford University, MS from MIT, and BS from the U.S. Naval Academy.
Max Maginness Max Maginness, Ph.D. - President and Chief Operating Officer
Dr. Maginness has extensive experience in moving from concepts to robust, reliable and cost effective products in both FDA–regulated and other industries. As co-founder of Healionics, Dr. Maginness has led the company’s R&D efforts since inception. He has 30 years of experience in managing multiple new product development and technology transfer projects for Siemens Medical, ATL (now Philips Ultrasound) and subsidiaries of CIBA-Geigy. These included complex multi-company and multinational projects in Europe, Japan, Korea and India. Earlier, Dr. Maginness held research positions at Stanford University and worked on technology development and business planning for startups.
Andrew Marshall Andrew Marshall, Ph.D. - Director and Chief Technology Officer
Dr. Marshall was named one of 40 Under 40 influential leaders and innovators shaping the MedTech industry by MD+DI magazine in 2012. As the co-inventor of Healionics' STAR biomaterial, he has over 12 years of experience working directly with this technology for improving biointegration of implantable medical devices, and he has been involved in test implant and device design for nearly 50 animal studies on STAR biomaterials. At the 3rd TERMIS World Congress 2012 in Vienna, Dr. Marshall was awarded the Innovation/Commercialization Award "for the application of tissue engineering and regenerative medicine in the production of a product or technology that will ultimately benefit patients." He serves on Healionics' Board of Directors and on the Scientific Advisory Board for Healionics' Belgium-based ophthalmic device focused subsidiary, iSTAR Medical. He has held past positions as a medical device validation engineer for Kemper-Masterson, Inc. and as a design engineer for Boeing Defense and Space Group. He earned a PhD in Chemical Engineering from the University of Washington and a BSE in Biomechanical Engineering from Stanford University.
Arthur Coury Arthur Coury, Ph.D. - Director
Dr. Coury's has more than 40 years of expertise in the field of Biomaterials. He was recognized as one of "100 Notable People in the Medical Device Industry" by MD&DI magazine in 2008, and was elected to the National Academy of Engineering in 2009. Dr. Coury's broad experience in senior management roles include: Director, Polymer Technology (1988-1993) and Corporate Research Fellow (1983-1993) at Medtronic, Inc.; Vice President, Research (1993-2000) and Chief Scientific Officer (1998-2000) at Focal, Inc.; and Vice President, Biomaterials Research at Genzyme Corporation (2000-2008). Dr. Coury holds a B.S. degree in chemistry from the University of Delaware (1962), a Ph.D. in organic chemistry (1965) and an M.B.A. (1980) from the University of Minnesota.
Buddy RatnerBuddy D. Ratner, Ph.D. - Director
Buddy D. Ratner is the co-inventor of STAR biomaterial. Dr. Ratner is the Michael L. and Myrna Darland Endowed Chair in Technology Commercialization, Professor of Bioengineering and Professor of Chemical Engineering at the University of Washington. He received his Ph.D. (1972) in polymer chemistry from the Polytechnic Institute of Brooklyn. Professor Ratner is a past president of the Society for Biomaterials, a fellow of the American Institute of Medical and Biological Engineering (AIMBE), a fellow of AVS The Science and Technology Society and a Fellow, Biomaterials Science and Engineering (FBSE). He served as president of AIMBE, 2002-2003. He was vice president of the Tissue Engineering Society International (TESI) 2003-2005. In 2002 he was elected a member of the National Academy of Engineering, USA. Ratner is the author of more than 400 scholarly works. His research interests include biomaterials, tissue engineering, polymers, biocompatibility, surface analysis of organic materials, self-assembly, nanobiotechnology and RF-plasma thin film deposition. He has won the Clemson Award for Contributions to the Biomaterials Literature, the C.M.A. Stine Award in Materials Science (AIChE), the Medard W. Welch Award (AVS) and the 2005-6 C. William Hall Award of the Society for Biomaterials. Dr. Ratner was most recently elected a Fellow of the American Association For the Advancement of Science (AAAS).

Back to top